60 - Brigatinib vs crizotinib in ALK TKI-naive ALK+ NSCLC: final results from ALTA-1L
- Resource Type
- Abstract
- Authors
- Popat, Sanjay; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James; Han, Ji-Youn; Hochmair, Maximilian; Lee, Ki Hyeong; Delmonte, Angelo; Garcia Campelo, Maria; Kim, Dong-Wan; Griesinger, Frank; Felip, Enriqueta; Califano, Raffaele; Spira, Alexander; Gettinger, Scott; Tiseo, Marcello; Lin, Huamao; Liu, Yuyin; Vranceanu, Florin; Camidge, D
- Source
- In Lung Cancer March 2022 165 Supplement 1:S27-S28
- Subject
- Language
- ISSN
- 0169-5002